Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Tags
Autins
Tag:
Autins
Shares
AIM weekly movers: Futura Medical considering options
Andrew Hore
-
21/09/2025
0
Shares
AIM movers: Nexteq Brazilian order and Autins hit be production halt at JLR
Andrew Hore
-
17/09/2025
1
Shares
AIM movers: Autins recovers despite tariff concerns
Andrew Hore
-
29/06/2025
1
Shares
AIM movers: Autins expects to return to profit and AccysTehnologies starts Accoya production in US
Andrew Hore
-
24/06/2025
5
Shares
AIM movers: China export controls for tungsten help Guardian Metal Resources and Celadon Pharmaceuticals still waiting for cash
Andrew Hore
-
18/11/2024
0
Shares
AIM movers: Challenger Energy farm-out deal with Chevron and UK Oil & Gas share consolidation
Andrew Hore
-
06/03/2024
1
Shares
Autins continues recovery and appoints new boss
Andrew Hore
-
04/03/2024
1
Shares
AIM movers: Vast Resources increases production and Nicola Foulston ousted at RBG Group
Andrew Hore
-
31/01/2023
0
Shares
Braveheart Investment increases Autins stake
Andrew Hore
-
20/10/2022
6
Shares
AIM movers: Evgen drug deal and no oil at Serenity for Europa and i3 Energy
Andrew Hore
-
10/10/2022
0
1
2
Page 1 of 2
Most Read
FTSE 100: Natwest slips as RELX and Experian bounce
13/02/2026
AIM movers: SkinBioTherapeutics chief executive resigns and Tekmar wins order
13/02/2026
SigmaRoc: up 29.5% in five months, Finals by end-March, shares 143.80p, TP 216p
13/02/2026
00:31:02
Nick Train: Pursuing superior returns in FTSE 100 AI beneficiaries
13/02/2026